Last reviewed · How we verify
Brimonidine Eye Drops in the Prevention of Myopia Progression
Study to determine the efficacy of alpha-2 adrenergic drugs (brimonidine) in the prevention of myopia progression. Given that the drugs used so far have limited efficacy and side effects (loss of near vision, photophobia), it may be an interesting contribution to such treatment at low cost, and to avoid the expense of managing the complications of myopia that develop throughout life.
Details
| Lead sponsor | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
|---|---|
| Phase | Phase 2 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 40 |
| Start date | 2025-07 |
| Completion | 2027-07 |
Conditions
- Myopia
Interventions
- Treatment with brimonidine eye drops 0.025%
Primary outcomes
- Effect of brimonidine eye drops 0.025% on myopia progression in children aged 6 to 14 years — 24 months
Progression of myopia (change in spherical equivalent of refractive error) measured every 6 months (Auto-refractometry and Subjective refraction)
Countries
Spain